Astena HoldingsAstena Holdings Co., Ltd.8095東証プライム卸売業FY ending Nov 2025, consolidated, J-GAAP
About 36% of Astena Holdings's sales come from Fine Chemicals, with Health and Beauty Care, Food and Medical making up much of the rest.
Out of every ¥100 of sales, about ¥5 is left as operating profit.
Revenue changed +11.6% from the prior year, operating profit +149.6%.
Revenue +11.6% · profit +149.6%, calculated from disclosed figures.
Operating leverage: 12.94× (profit growth ÷ revenue growth)
FY ending Nov 2023 → FY ending Nov 2024
FY ending Nov 2023 → FY ending Nov 2024
For every ¥100 Astena Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書-第86期(2024/12/01-2025/11/30)
EDINET (FSA Japan)
有価証券報告書-第85期(2023/12/01-2024/11/30)
EDINET (FSA Japan)
有価証券報告書-第84期(2022/12/01-2023/11/30)
EDINET (FSA Japan)
有価証券報告書-第83期(2021/12/01-2022/11/30)
EDINET (FSA Japan)
有価証券報告書-第82期(令和2年12月1日-令和3年11月30日)
EDINET (FSA Japan)
有価証券報告書-第81期(令和1年12月1日-令和2年11月30日)
Extracted from XBRL: 54 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.